Review of real-world studies on capmatinib use in MET-mutated lung cancer
Lung cancer occupies a leading position in the structure of mortality from malignant neoplasms, so in 2022, mortality from lung cancer was 31.66 per 100,000 population, in 2022, 44,981 patients were registered with a diagnosis of lung cancer for the first time in their life, the one-year mortality r...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Publishing House OKI
2025-04-01
|
Series: | Реальная клиническая практика: данные и доказательства |
Subjects: | |
Online Access: | https://www.myrwd.ru/jour/article/view/87 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|